HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Gin Selected Research

Noninsulin-dependent diabetes mellitus with deafness

8/2009The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes.
9/2008Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study.
1/2004Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD).
5/2001Maternally inherited diabetes and deafness: a multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Gin Research Topics

Disease

11Type 2 Diabetes Mellitus (MODY)
03/2015 - 05/2001
5Weight Loss (Weight Reduction)
05/2008 - 06/2000
5Insulin Resistance
11/2002 - 09/2000
4Body Weight (Weight, Body)
11/2011 - 01/2004
4Weight Gain
12/2009 - 06/2000
4Noninsulin-dependent diabetes mellitus with deafness
08/2009 - 05/2001
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 09/2006
3Chronic Renal Insufficiency
03/2015 - 11/2008
3Hyperglycemia
02/2011 - 06/2000
3Ketosis
12/2006 - 06/2000
3Hypoglycemia (Reactive Hypoglycemia)
12/2003 - 06/2001
2Diabetes Complications
01/2017 - 09/2013
2Pain (Aches)
01/2017 - 11/2011
2Diabetic Neuropathies (Diabetic Neuropathy)
12/2011 - 01/2001
2Hypertension (High Blood Pressure)
02/2011 - 09/2004
2Obesity
09/2004 - 07/2002
2Overweight
09/2004 - 05/2001
1Peripheral Nervous System Diseases (PNS Diseases)
01/2017
1Neoplasms (Cancer)
03/2012
1Polyneuropathies (Polyneuropathy)
12/2011
1Proteinuria
11/2011
1Hypertriglyceridemia
02/2011
1Sensorineural Hearing Loss
08/2009
1MELAS Syndrome (Syndrome, MELAS)
08/2009
1Mitochondrial Diseases (Mitochondrial Disease)
09/2008
1Gestational Diabetes (Gestational Diabetes Mellitus)
12/2006
1Autoimmune Diseases (Autoimmune Disease)
11/2006
1Hashimoto Disease (Thyroiditis, Hashimoto)
11/2006
1Hyperthyroidism
11/2006
1Vitiligo
11/2006
1Rheumatoid Arthritis
09/2006
1Parkinson Disease (Parkinson's Disease)
05/2006
1Chronic Disease (Chronic Diseases)
12/2004
1Cystitis
09/2004
1Chronic Pancreatitis
09/2004
1Diabetic Foot
08/2004
1Atrial Fibrillation
06/2002
1Anemia
08/2001
1Inflammation (Inflammations)
08/2001
1Acidosis
07/2001
1Sleep Apnea Syndromes (Sleep Apnea)
05/2001
1Obstructive Sleep Apnea
05/2001

Drug/Important Bio-Agent (IBA)

15Insulin (Novolin)FDA Link
09/2014 - 03/2000
7Glucose (Dextrose)FDA LinkGeneric
09/2013 - 06/2000
4Mitochondrial DNA (mtDNA)IBA
08/2009 - 05/2001
3Advanced Glycation End ProductsIBA
01/2017 - 09/2013
3LipidsIBA
09/2004 - 07/2000
2NAD (NADH)IBA
12/2011 - 01/2001
2Blood Glucose (Blood Sugar)IBA
12/2009 - 06/2001
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2008 - 09/2007
2Antihypertensive Agents (Antihypertensives)IBA
05/2008 - 09/2007
2ThiazidesIBA
05/2008 - 09/2007
2SodiumIBA
05/2008 - 09/2007
2Proteins (Proteins, Gene)FDA Link
08/2001 - 07/2000
2Glucagon (Glukagon)FDA Link
06/2000 - 06/2000
1Syntex adjuvant formulationIBA
01/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
09/2014
1BiguanidesIBA
03/2012
1Insulin Glargine (Lantus)FDA Link
03/2012
1Indicators and Reagents (Reagents)IBA
12/2011
1Pharmaceutical PreparationsIBA
11/2011
1CreatinineIBA
11/2011
1HDL LipoproteinsIBA
02/2011
1CholesterolIBA
02/2011
1HDL CholesterolIBA
02/2011
1Insulin Detemir (Levemir)FDA Link
12/2009
1Cystatin CIBA
11/2008
1Retinaldehyde (Retinal)IBA
09/2008
1Angiotensin Receptor AntagonistsIBA
09/2007
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2007
1CarbohydratesIBA
12/2006
1KetonesIBA
12/2006
1Anti-Idiotypic AntibodiesIBA
11/2006
1Insulin AntibodiesIBA
11/2006
1Intrinsic FactorFDA Link
11/2006
1AntibodiesIBA
11/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2006
1GhrelinIBA
05/2006
1Triglycerides (Triacylglycerol)IBA
07/2005
1AntioxidantsIBA
12/2004
1LDL CholesterolIBA
09/2004
1Orlistat (Xenical)FDA Link
09/2004
1LDL Lipoproteins (beta Lipoproteins)IBA
09/2004
1Vitamin EFDA LinkGeneric
08/2004
1Hemoglobins (Hemoglobin)IBA
01/2004
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
11/2002
1PPAR gammaIBA
07/2002
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2002
1Messenger RNA (mRNA)IBA
07/2002
1GlycogenIBA
08/2001
1Glutamine (L-Glutamine)FDA Link
08/2001
1Amino AcidsFDA Link
08/2001
1Adenosine Triphosphate (ATP)IBA
07/2001
1DNA (Deoxyribonucleic Acid)IBA
05/2001
1Oxygen (Dioxygen)IBA
05/2001

Therapy/Procedure

5Therapeutics
11/2011 - 03/2000
2Glycemic Control
09/2004 - 06/2001
2Protein-Restricted Diet (Diet, Protein Restricted)
03/2001 - 07/2000
1Combination Drug Therapy (Combination Chemotherapy)
11/2002
1Electric Countershock (Cardioversion)
06/2002